IntriCon Partner Advanced Medical Electronics Awarded U.S. Government Research Grants
IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of body-worn medical and electronics devices, announced that its strategic partner, Minneapolis-based Advanced Medical Electronics Corp. (AME), is participating in two new research grants from the U.S. Government.
The first, from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), supports development of an ultra-miniature, body-worn technology platform for recording signals from skin electrodes. This core capability can be applied to:
In addition to further development of this core recording platform, the grant will support testing and Food and Drug Administration (FDA) submission.
“The funding that AME received will be used to further advance and commercialize our ultra-low power PhysioLink™ wireless technology platform,” said Mark S. Gorder, president and chief executive officer of IntriCon. “This includes aggressive development of the electronics and device enclosure that will comprise our next-generation ambulatory ECG products, among other body-worn monitoring applications.”In addition to the NIBIB funding, AME also is a collaborator on a grant from the National Institute on Disability and Rehabilitation Research (NIDRR). This phase-one grant is for additional research and feasibility testing for solid-state sensor technology that will ultimately replace aging telecoil sensor technology in hearing aids. Said Gorder, “Ultimately, this funding will allow AME and IntriCon to explore the possibility of creating hearing aid devices that work better with personal electronics such as land-line and mobile phones, iPods and other listening devices. Right now hearing aid users have to orient their head or the device to achieve the optimal signal—and that can be problematic at best. New technology will eliminate that and also result in smaller overall devices.”
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV